Titrated baclofen for high-risk alcohol consumption: a randomized placebo-controlled trial in out-patients with 1-year follow-up

L. RIGAL ; S. SIDORKIEWICZ ; J. M. TRELUYER ; E. PERRODEAU ; C. LE JEUNNE ; R. PORCHER ; P. JAURY | 2020
Dans Addiction (Vol.115, n°7, July 2020) Article : Périodique

Background and Aims: Baclofen is a promising drug for treating patients with alcohol-related disorders. Nevertheless, the first randomized clinical trials (mainly with target doses) reported inconsistent efficacy, possibly because of the effecti[...]

Plus d'info

Ajouter à la sélection

Lien externe